|
1
|
Winters BD, Eberlein M, Leung J, Needham
DM, Pronovost PJ and Sevransky JE: Long-term mortality and quality
of life in sepsis: A systematic review. Crit Care Med.
38:1276–1283. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ani C, Farshidpanah S, Bellinghausen
Stewart A and Nguyen HB: Variations in organism-specific severe
sepsis mortality in the United States: 1999–2008. Crit Care Med.
43:65–77. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Angus DC and Wax RS: Epidemiology of
sepsis: An update. Crit Care Med. 29 (7 Suppl):S109–S116. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seymour CW, Liu VX, Iwashyna TJ,
Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM,
Shankar-Hari M, Singer M, et al: Assessment of clinical criteria
for sepsis: For the third international consensus definitions for
sepsis and septic shock (Sepsis-3). JAMA. 315:762–774. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nathan C: Points of control in
inflammation. Nature. 420:846–852. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ulloa L and Tracey KJ: The ‘cytokine
profile’: A code for sepsis. Trends Mol Med. 11:56–63. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schuh K and Pahl A: Inhibition of the MAP
kinase ERK protects from lipopolysaccharide-induced lung injury.
Biochem Pharmacol. 77:1827–1834. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Everhart MB, Han W, Sherrill TP, Arutiunov
M, Polosukhin VV, Burke JR, Sadikot RT, Christman JW, Yull FE and
Blackwell TS: Duration and intensity of NF-kappaB activity
determine the severity of endotoxin-induced acute lung injury. J
Immunol. 176:4995–5005. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Toussaint S and Gerlach H: Activated
protein C for sepsis. N Engl J Med. 361:2646–2652. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deutschman CS and Tracey KJ: Sepsis:
Current dogma and new perspectives. Immunity. 40:463–475. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tracey KJ: Physiology and immunology of
the cholinergic antiinflammatory pathway. J Clin Invest.
117:289–296. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ulloa L: The vagus nerve and the nicotinic
anti-inflammatory pathway. Nat Rev Drug Discov. 4:673–684. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang H, Liao H, Ochani M, Justiniani M,
Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, et al:
Cholinergic agonists inhibit HMGB1 release and improve survival in
experimental sepsis. Nat Med. 10:1216–1221. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang H, Yu M, Ochani M, Amella CA, Tanovic
M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, et al:
Nicotinicacetylcholine receptor7 subunit is an essential regulator
of inflammation. Nature. 421:384–388. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leonard S and Bertrand D: Neuronal
nicotinic receptors: From structure to function. Nicotine Tob Res.
3:203–223. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kalamida D, Poulas K, Avramopoulou V,
Fostieri E, Lagoumintzis G, Lazaridis K, Sideri A, Zouridakis M and
Tzartos SJ: Muscle and neuronal nicotinic acetylcholine receptors.
Structure, function and pathogenicity. FEBS J. 274:3799–3845. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huston JM, Ochani M, Rosas-Ballina M, Liao
H, Ochani K, Pavlov VA, Gallowitsch-Puerta M, Ashok M, Czura CJ,
Foxwell B, et al: Splenectomy inactivates the cholinergic
antiinflammatory pathway during lethal endotoxemia and
polymicrobial sepsis. J Exp Med. 203:1623–1628. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bodnar AL, Cortes-Burgos LA, Cook KK, Dinh
DM, Groppi VE, Hajos M, Higdon NR, Hoffmann WE, Hurst RS, Myers JK,
et al: Discovery and structure-activity relationship of
quinuclidine benzamides as agonists of alpha7 nicotinic
acetylcholine receptors. J Med Chem. 48:905–908. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Mathieu SL, Harris R, Ji J, Anderson
DJ, Malysz J, Bunnelle WH, Waring JF, Marsh KC, Murtaza A, et al:
Role of α7 nicotinic acetylcholine receptors in regulating tumor
necrosis factor-α (TNF-α) as revealed by subtype selective
agonists. J Neuroimmunol. 239:37–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duris K, Manaenko A, Suzuki H, Rolland WB,
Krafft PR and Zhang JH: α7 nicotinic acetylcholine receptor agonist
PNU-282987 attenuates early brain injury in a perforation model of
subarachnoid hemorrhage in rats. Stroke. 42:3530–3536. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li F, Chen Z, Pan Q, Fu S, Lin F, Ren H,
Han H, Billiar TR, Sun F and Li Q: The protective effect of
PNU-282987, a selective α7 nicotinic acetylcholine receptor
agonist, on the hepatic ischemia-reperfusion injury is associated
with the inhibition of high-mobility group box1 protein expression
and nuclear factor κB activation in mice. Shock. 39:197–203.
2013.PubMed/NCBI
|
|
22
|
Su X, Lee JW, Matthay ZA, Mednick G,
Uchida T, Fang X, Gupta N and Matthay MA: Activation of the alpha7
nAChR reduces acid-induced acute lung injury in mice and rats. Am J
Respir Cell Mol Biol. 37:186–192. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ding X, Wang X, Zhao X, Jin S, Tong Y, Ren
H, Chen Z and Li Q: RGD peptides protects against acute lung injury
in septic mice through Wisp1-integrin β6 pathway inhibition. Shock.
43:352–360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Z, Ding X, Jin S, Pitt B, Zhang L,
Billiar T and Li Q: WISP1-αvβ3 integrin signaling positively
regulates TLR-triggered inflammation response in sepsis induced
lung injury. Sci Rep. 6:288412016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei W, Dejie L, Xiaojing S, Tiancheng W,
Yongguo C, Zhengtao Y and Naisheng Z: Magnolol inhibits the
inflammatory response in mouse mammary epithelial cells and a mouse
mastitis model. Inflammation. 38:16–26. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaminska B: MAPK signalling pathways as
molecular targets for anti-inflammatory therapy-from molecular
mechanisms to therapeutic benefits. Biochim Biophys Acta.
1754:253–262. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pinheiro NM, Santana FP, Almeida RR,
Guerreiro M, Martins MA, Caperuto LC, Câmara NO, Wensing LA, Prado
VF, Tibério IF, et al: Acute lung injury is reduced by the α7nAChR
agonist PNU-282987 through changes in the macrophage profile. FASEB
J. 31:320–322. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He Y, Ye ZQ, Li X, Zhu GS, Liu Y, Yao WF
and Luo GJ: Alpha7 nicotinic acetylcholine receptor activation
attenuated intestine-derived acute lung injury. J Surg Res.
201:258–265. 2106. View Article : Google Scholar
|
|
30
|
Bode JG, Ehlting C and Häussinger D: The
macrophage response towards LPS and its control through the
p38(MAPK)-STAT3 axis. Cell Signal. 24:1185–1194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Borovikova LV, Ivanova S, Zhang M, Yang H,
Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW and Tracey
KJ: Vagus nerve stimulation attenuates the systemic inflammatory
Response to endotoxin. Nature. 405:458–462. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li DL, Liu JJ, Liu BH, Hu H, Sun L, Miao
Y, Xu HF, Yu XJ, Ma X, Ren J and Zang WJ: Acetylcholine inhibits
hypoxia-induced tumor necrosis factor-α production via regulation
of MAPKs phosphorylation in cardiomyocytes. J Cell Physiol.
226:1052–1059. 2011. View Article : Google Scholar : PubMed/NCBI
|
